Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Oct;3(10):573-7.
doi: 10.1038/ncpneph0598.

Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure

Affiliations
Case Reports

Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure

Mohan Rajapurkar et al. Nat Clin Pract Nephrol. 2007 Oct.

Abstract

Background: A 40-year-old female presented to hospital with rapidly progressive renal failure secondary to antineutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis. She was started on immunosuppressive therapy (oral steroids and oral cyclophosphamide) and hemodialysis. She re-presented with persistent fever, persistent vomiting and dry cough 135 days after starting immunosuppression. A chest X-ray revealed left lower zone consolidation. Repeated sputum Gram stains were negative, and both sputum and blood cultures were sterile. A sputum smear was negative for acid-fast bacilli. The patient's fever did not respond to empirical antibiotics or antitubercular therapy. Bronchoscopic alveolar lavage and stool examination revealed larval forms of Strongyloides stercoralis.

Investigations: Physical examination, urine and blood analyses, chest X-ray, bronchoscopy and bronchoalveolar lavage examination.

Diagnosis: Respiratory hyperinfection syndrome due to S. stercoralis.

Management: Ivermectin, albendazole and empirical broad-spectrum antibiotics for bacterial superinfection (amoxicillin and clavulanic acid for 5 days followed by piperacillin and tazobactam plus levofloxacin).

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources